GDM(002636)2024-07-12 08:27Financial Performance - The estimated net profit attributable to shareholders for the first half of 2024 is projected to be between 60 million and 80 million CNY, representing an increase of 428.63% to 604.85% compared to 11.35 million CNY in the same period last year[3]. - The net profit after deducting non-recurring gains and losses is expected to be between 0 and 5 million CNY, recovering from a loss of 2.92 million CNY in the previous year[3]. - Basic earnings per share are anticipated to be between 0.082 CNY and 0.110 CNY, compared to 0.016 CNY per share in the same period last year[3]. Factors Influencing Profit - The significant increase in net profit is primarily due to an investment income of approximately 77.1 million CNY from the transfer of 80% equity in the subsidiary Chengde Tianyuan Pharmaceutical Co., Ltd.[5]. - The company has improved internal management, optimized product structure, and increased the utilization rate of new production capacity, leading to a rise in the sales volume of copper-clad laminates and a slight increase in sales prices[5]. Caution and Verification - The financial data presented in the earnings forecast has not been audited by an accounting firm, and the final figures will be confirmed in the company's semi-annual report[4]. - Investors are advised to exercise caution as the earnings forecast is based on preliminary calculations by the company's finance department[6].